Assertion list
new drug (subgroup of drug ) → ReceivesAction
Results from Ascent++: 58
new drug → ReceivesAction → approved by the fda 0.76
new drug → ReceivesAction → approved 0.69
new drug → ReceivesAction → tested 0.67
new drug → ReceivesAction → brought to market 0.66
new drug → ReceivesAction → developed 0.64
new drug → ReceivesAction → created 0.59
new drug → ReceivesAction → tested in clinical trials 0.57
new drug → ReceivesAction → sold 0.55
new drug → ReceivesAction → introduced 0.55
new drug → ReceivesAction → proven safe 0.54
new drug → ReceivesAction → described in section 505(a 0.54
new drug → ReceivesAction → tested on animal 0.54
new drug → ReceivesAction → prescribed 0.53
new drug → ReceivesAction → investigated 0.53
new drug → ReceivesAction → patented 0.52
new drug → ReceivesAction → synthesized 0.51
new drug → ReceivesAction → released 0.47
new drug → ReceivesAction → protected by patent 0.46
new drug → ReceivesAction → added 0.46
new drug → ReceivesAction → marketed 0.44
new drug → ReceivesAction → launched 0.42
new drug → ReceivesAction → compared with placebo 0.42
new drug → ReceivesAction → approved in the u.s. 0.40
new drug → ReceivesAction → injected into the eye 0.40
new drug → ReceivesAction → reviewed 0.39
new drug → ReceivesAction → reimbursed 0.38
new drug → ReceivesAction → studied 0.36
new drug → ReceivesAction → licensed for use 0.35
new drug → ReceivesAction → discovered 0.34
new drug → ReceivesAction → started 0.34
new drug → ReceivesAction → tested on mouse 0.32
new drug → ReceivesAction → registered 0.31
new drug → ReceivesAction → tested against placebo 0.31
new drug → ReceivesAction → added to the formulary 0.28
new drug → ReceivesAction → approved by health canada 0.28
new drug → ReceivesAction → approved in 2015 0.28
new drug → ReceivesAction → approved in 2017 0.28
new drug → ReceivesAction → had to clear high bar 0.28
new drug → ReceivesAction → presented as breakthrough 0.28
new drug → ReceivesAction → studied in child 0.28
new drug → ReceivesAction → used in combination 0.28
new drug → ReceivesAction → approved for public use 0.25
new drug → ReceivesAction → approved under anda 0.25
new drug → ReceivesAction → close to decade 0.25
new drug → ReceivesAction → developed by amgen 0.25
new drug → ReceivesAction → intended for use 0.25
new drug → ReceivesAction → launched in canada 0.25
new drug → ReceivesAction → required 0.25
new drug → ReceivesAction → targeted 0.25
new drug → ReceivesAction → tested in the united states 0.25
new drug → ReceivesAction → tested on cell 0.25
new drug → ReceivesAction → used in concert 0.25
new drug → ReceivesAction → developed to treat tb 0.23
new drug → ReceivesAction → intended to treat serious condi… 0.23
new drug → ReceivesAction → tolerated 0.19
new drug → ReceivesAction → used at lower doses 0.19
new drug → ReceivesAction → removed 0.09
new drug → ReceivesAction → approved for motor neurone dise… 0.00